Activation of prodrugs by targeted enzymes (Q67904832)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

19 September 2019

title

Activation of prodrugs by targeted enzymes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

6 December 2022

author name string

K. E. Hellström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1835844

6 December 2022

P. D. Senter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:1835844

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1835844

6 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

https://api.elsevier.com/content/article/PII:027753799195003V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

https://api.elsevier.com/content/article/PII:027753799195003V?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

European Journal of Cancer

6 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

19 September 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

19 September 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

1342-1343

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

A cytotoxic agent can be generated selectively at cancer sites

19 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

The First Bagshawe lecture. Towards generating cytotoxic agents at cancer sites

6 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice

6 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate

6 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

Enhancement of the in vitro and in vivo antitumor activities of phosphorylated mitomycin C and etoposide derivatives by monoclonal antibody-alkaline phosphatase conjugates

6 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

Activation of prodrugs by antibody-enzyme conjugates: a new approach to cancer therapy.

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

Antibody-penicillin-V-amidase conjugates kill antigen-positive tumor cells when combined with doxorubicin phenoxyacetamide

6 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

Cytotoxicity and activation of CB1954 in a human tumour cell line

6 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)95003-V

6 December 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1835844 AND SRC:MED&resulttype=core&format=json

19 September 2019

1 reference